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ABSTRACT
We describe a new program called cryptic splice
finder (CSF) that can reliably identify cryptic splice
sites (css), so providing a useful tool to help inves-
tigate splicing mutations in genetic disease. We
report that many css are not entirely dormant and
are often already active at low levels in normal
genes prior to their enhancement in genetic disease.
We also report a fascinating correlation between the
positions of css and introns, whereby css within the
exons of one species frequently match the exact
position of introns in equivalent genes from another
species. These results strongly indicate that many
introns were inserted into css during evolution and
they also imply that the splicing information that lies
outside some introns can be independently recogn-
ized by the splicing machinery and was in place prior
to intron insertion. This indicates that non-intronic
splicing information had a key role in shaping the
split structure of eukaryote genes.
INTRODUCTION
Eukaryotic genomes contain large numbers of splice sites,
known as cryptic splice sites (css), which are generally held
to be disadvantageous sites that are dormant or used only
at low levels unless activated by mutation of nearby au-
thentic or advantageous splice sites (1,2). Once activated,
css may be used extremely efﬁciently, resulting in a wide
range of genetic disease (3–5). It is generally accepted that
css are suppressed by nearby stronger splice sites and that
splice site selection can be viewed as a competition
between the various potential splice sites in a pre-mRNA
for the splicing machinery (1,2).
For genes with many introns it is suspected that up to
50% of mutations that cause disease do so by affecting
splicing, either through the activation of css, exon
skipping or disruption of alternative splicing (4–7). Css
are found in exons as well as introns and their recognition
by the splicing machinery is similar to splice site recogni-
tion in general and is dependent upon information both at
the splice site and outside this region at enhancer and
silencer sequences (8–10).
It is important to be able to predict the positions of css
that might be activated in genetic disease and a number of
DNA-sequence scanning programs have been developed
for this purpose. Such programs are often highly inform-
ative but are handicapped by the complex nature of the
nucleotide information that is required to deﬁne a splice
site (4,8,11,12).
Our previous work indicates a connection between css
and introns. We identiﬁed a small number of css in the
exon regions of actin genes by experiment and discovered
that eight out of nine of these exonic css sites exactly
match the positions of introns in actin genes from other
species, which led us to conclude that these particular
actin introns were inserted into css during evolution
(13,14). This ﬁnding may help to explain why and how
eukaryotes acquired introns; however, it is important to
establish if our results for the actin gene family are gener-
ally applicable.
We have been unable to identify a DNA-scanning
program that reveals the same strong correlation between
predicted actin css and intron positions that we observed
through experiments (13). However, this is probably
because DNA-scanning programs were not designed spe-
ciﬁcally for this purpose and because of the difﬁculties
such programs face in distinguishing between css and
false-positive non-functional splice sites (12). Here, we de-
scribe a program called cryptic splice ﬁnder (CSF) that can
reliably identify css by EST-to-genomic alignment. It does
this by identifying transcripts that have been generated
through the low level use of css by normal genes. Unlike
the scanning programs, CSF cannot predict the position
of splice sites that are created de novo by gene mutation.
However, this program provides a useful complementary
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us to establish that there is a strong and general correl-
ation between the positioning of css and of introns. The




predicts css based on spliced alignment of ESTs. Each
EST is aligned against the genome independently from
other ESTs. In order to be considered by CSF, a gap in
the alignment must be ﬂanked by a minimum number (25
by default) of matching residues. CSF searches for EST
alignments that form the patterns illustrated in Figure 1A.
It can be seen that the majority of ESTs must share a
common gap or deletion and in addition must include
minor transcripts that share only one of the common
deletion endpoints. CSF deﬁnes the common deletion
endpoints as authentic splice sites and the deletion end
point of the minor transcript(s) as cryptic or alternative
splice sites (arrowed). For constitutively spliced genes,
these minor deletion endpoints occur very infrequently
and are therefore candidate css. For alternatively spliced
genes, CSF identiﬁes both css and more frequently
occurring alternative splice sites (see ‘Results’ section).
As illustrated in Figure 1A, css can be 50 or 30 and
upstream or downstream of the alternative authentic
splice site. In the majority of cases the authentic splice
sites deﬁned by CSF are the same as the splice sites
deﬁned by reference sequences (i.e. NM_000518.4) and
so represent commonly used splice sites (see below for
exceptions).
In more detail, coordinates of the splice sites from
adjacent exon–intron–exon sequences are pooled into
four-tuples which are then loaded into a relational
database alongside the data linking them to their align-
ments. The database runs a query to detect tuple pairs
satisfying the css condition: the overlapping introns
match at one end and mismatch at the other, with a mis-
matching intron end from one tuple residing within the
exon from the other tuple. For each tuple pair returned
by the query, the splice sites of the intron that has more
supporting ESTs are declared authentic and the remaining
site is declared cryptic. Splice site coordinates are mapped
against the NCBI36/hg18 human genome assembly.
As illustrated (Figure 1A), a css detected by CSF is fur-
ther classiﬁed as to whether it is a 50 or 30 css and whether
it is located in an exon or intron. The number of tran-
scripts supporting a splice (either authentic or css), is
printed and the complete list of such ESTs is linked
under the count. Where applicable, the count is followed
by a number in parentheses. For exonic css, parentheses
always appear on the left-hand (authentic) side of the CSF
report and on the right-hand side (cryptic) for intronic css.
The numbers in parentheses show the transcripts that
formally satisfy the css conditions (see Notes about CSF
section).
Notes about CSF. CSF only lists authentic 50- and
30-splice sites when one of the two authentic splice sites
is a more common alternative for another nearby splice
site that is listed under the cryptic (alternative) column.
This means that CSF only lists a subset of the total
number of authentic splice sites for any one gene.
CSF provides a very good way of screening large
numbers of transcripts for the minority that are likely to
have been generated by use of a css or nearby alternative
splice site. However, candidate transcripts do need to be
checked, by for example, using the Splign alignment option
(15). CSF classiﬁes a minority of less well-supported dele-
tions as authentic splices because these happen to meet
the CSF conditions. These sites can be easily recognized
from the CSF output because they have lower levels of
support than other authentic splice sites and do not
match reference sequence splice sites. Caution needs to
be taken with the interpretation of these particular
‘authentic’ splice sites and also with the interpretation
of css that are paired with authentic splice sites that
have a low-parenthesis score. See Supplementary Data
for illustrative examples.
Searching CSF. Two methods of searching for css are
provided (Supplementary Figure S1). In the ﬁrst method,
a landmark EST accession is submitted and CSF returns a
list of css within the genomic range of the entered EST.
In the second method, an arbitrary genomic interval can
be speciﬁed and CSF will return a hierarchic list of css for
that interval. Entire chromosomes can also be entered
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Figure 1. (A) CSF searches for transcript alignments that form one of
four patterns (i–iv). All of these patterns contain a group of major
transcripts that share a common deletion and a minor transcript that
shares only one of the deletion endpoints. CSF deﬁnes the common
deletion endpoints as authentic splice sites and the less common
deletion endpoint of the minor transcript(s) as cryptic or alternative
splice sites (arrowed). (B) Schematic of the HBB gene for human
b-globin, which contains two introns that are constitutively spliced
from pre-mRNA. As illustrated the vast majority of ESTs align as
shown and deﬁne the three exons of this gene. The circle shows a
pattern of ESTs that CSF is designed to recognize and that is
reported in Figure 2A. The numbers in brackets show the genome co-
ordinates of the three splice sites that are identiﬁed and listed by CSF
(Figure 2A).
5838 Nucleic Acids Research, 2011,Vol.39, No. 14CSF currently lists 3232 css. Links are provided in order
to view the sequence alignments of individual css. CSF can
predict css for Homo sapiens, Bos taurus, Mus musculus,
Danio rerio and Arabidopsis thaliana and we intend to
expand this range as further transcript data becomes
available
Statistical analysis. There are 91 known different intron
positions within the coding region of the actin gene family,
these have been identiﬁed by sequencing actin genes
from over 160 different species (16–18). The positions of
all of these introns together with the 14 css that we have
identiﬁed are plotted in Supplementary Figure S2A. Actin
genes usually have 375 codons and therefore three times
this number of possible positions for introns or css and so
the probability of a single css exactly matching an intron
position by chance is 91/(3 375). The exact Fisher’s test
gives the P-value of 1.6 10
 10 for 11 or more matches
out of 14 occurring by chance. Similarly, we identiﬁed 135
css in the coding region of 51 different genes of the ribo-
somal protein gene database. The 51 genes are 190 codons
in size on average and have a total of 957 introns (from
22 species). The probability of a css exactly matching an
intron by chance is therefore 957/(190 3 51)=0.033.
The binomial probability of 33 or more matches out of
135 occurring by chance is P=2.2 10
 15.
RT–PCR. Total RNA was extracted using Trizol and the
cDNA ﬁrst strand was synthesized from 0.1mg of RNA
using superscript III (Invitrogen) and random hexamers.
PCR products were generated with Taq polymerase (NBI)
for 25 or 35 cycles and separated on 5% native polyacryl-
amide gels. PCR bands were excised and cloned into
pGEM-T Easy vectors (Promega) for sequencing by
colony PCR followed by ABI Prism Big Dye Terminator
cycle sequencing (Applied Biosystems).
RESULTS
Principle of css detection by CSF
Css are often used highly efﬁciently in genetic disease fol-
lowing the mutation of nearby more competitive splice
sites. We, therefore, reasoned that css might be used at a
low but detectable frequency by normal genes. Figure 1A
shows the patterns of EST alignments that CSF is designed
to identify. It can be seen that CSF identiﬁes groups of
ESTs or transcripts that share a common deletion, when
aligned to the genome, together with a minor transcript(s)
that shares just one of the common deletion endpoints.
CSF deﬁnes the common deletion endpoints as authentic
splice sites and the unusual deletion endpoint of the minor
transcript as a cryptic or alternative splice site (see
‘Materials and Methods’ section for further details).
Figure 1B illustrates how ESTs align to the human HBB
gene for b-globin, which has two introns. The circle
identiﬁes a pattern of alignments that is recognized by
CSF because it includes a minor transcript that has an
unusual deletion endpoint (position 5204752) that is a
predicted css (Figures 1B and 2A). The reason why such
css predictions turn out to be accurate (see below) is
because of the restriction that the predicted css is paired
with a commonly used splice site. This distinguishes
mRNA deletions that are generated by low-level aberrant
splicing from deletions that are generated by non-splicing
mechanisms such as errors during transcription or during
the generation of the EST.
Figure 2A shows the CSF output for HBB, which is one
of the ﬁrst genes in which css were identiﬁed (19). CSF
identiﬁes a single EST called BU198526 as having been
generated by aberrant splicing. BU198526 aligns to HBB
as illustrated in Figure 1B(ii), this alignment can be viewed
in detail by a link to Splign (Figure 2). As explained
above, the reason why BU198526 was identiﬁed by CSF
is because it forms a pattern alignment with other ESTs as
illustrated in Figure 1A(ii). The CSF output (Figure 2A)
shows that BU198526 shares a deletion endpoint at
position 52044605 that is in common with 703 other
ESTs (link provided) but differs in having an unusual 50
deletion endpoint at position 5204752, which is the pre-
dicted css. A comparison with the known css of HBB
conﬁrms that 5204752 is indeed a css (Supplementary
Table S1). We show below that css predictions by CSF
are very reliable even if supported by just a single EST,
as in this case. However, HBB has 11 known css
(Supplementary Table S1), which illustrates that CSF is
limited in its predictions, most probably by the amount of
available transcript data.
For alternatively spliced genes, CSF identiﬁes both css
and also nearby alternative splice sites that act to shorten
or lengthen exons. This is because the two types of splice
sites are rather similar. For example, the css identiﬁed in
HBB (Figure 2A) might be considered an alternative splice
site if used at a greater frequency than 1 in 703.
WT1 is an example of gene that encodes at least three
alternatively spliced mRNAs and for which there are only
80 ESTs. CSF identiﬁes two css (Figure 2B), however, the
CSF output also shows that the predicted css at
32370103, for example, is supported by ﬁve ESTs
including the reference sequence NM_000378.3 and that
the ‘authentic’ splice site nine bases away at 32370094 is
supported by only eight transcripts. The similar usage of
the authentic and css shows that these are really alterna-
tive 50 ss. However, it is useful to have this type of infor-
mation because alternative splice sites are also implicated
in genetic disease and in this particular case disruption of
the splice site at position 32370094 gives rise to Frasier
syndrome, possibly due to the increased use of splice site
32370103 (20,21).
To test CSF we analyzed a database called DBASS
(database of aberrant splice sites), which lists 340 human
genes that have one or more css that are activated in
genetic disease (3). There are 814 different css listed in
DBASS and CSF predicts 609 css from the same set of
340 genes. Fifty-eight percent of these predictions are sup-
ported by only single ESTs (Supplementary Table S1).
Before comparing the css identiﬁed by CSF with those
of DBASS, we ﬁrst asked whether the css predictions
that are supported by just single ESTs were likely to
have been generated by aberrant splicing. We reasoned
that because CSF identiﬁes deletion endpoints irrespective
of their sequence, then if these rare deletion endpoints
Nucleic Acids Research, 2011,Vol.39, No. 14 5839were generated by splicing they should look like splice
sites. The predictions were divided into 50 and 30 css and
Table 1 shows that the predicted css have a very good
match to the expected 50-o r3 0-splice site consensus se-
quence, which is a strong proof that the vast majority of
even the rarest deletions identiﬁed by CSF were generated
by aberrant splicing.
Of the two sets of DBASS and CSF css, only 46 are in
common (Supplementary Tables S1 and S2). However,
there are only 61 cases where the DBASS and CSF css
are located within the same exon or intron
(Supplementary Table S1, column 5), giving a match
rate of 46/61 or 75%. Thirteen of the 15 DBASS css
that did not match were either created de novo by
mutation and would, therefore, not be expected to be
identiﬁed by CSF or were of opposite type, for example,
a5 0 css in DBASS and a 30 css in CSF and would, there-
fore, be unlikely to match (Supplementary Table S1). Only
two out of 48 css predictions that could be meaningfully
compared with DBASS did not exactly match
(Supplementary Table S1). This result together with the
clear consensus sequence results shown in Table 1 indi-
cates that CSF predictions are highly reliable and can
only generate a very low level of false positives even
when supported by single ESTs. The small number of 46
css in common between the CSF database and DBASS
(Supplementary Table S1) presumably indicates that
both DBASS and CSF have identiﬁed relatively few of
all possible css within this set of 340 genes.
We conﬁrmed that css predicted by CSF could also be
detected by experiment. Five css predictions by CSF that
DBASS shows to be activated in patients were detected in
human cell lines that do not have the causative genetic
mutations (Figure 3, lanes 1–5). The last lane shows an
example of a css prediction by CSF that has not been
reported in patients. The PCR products marked with as-
terisks were conﬁrmed by sequencing (Supplementary
Figure S3). These results conﬁrmed the CSF predictions
and also show that the css we analyzed were already active
in a normal genetic background.
Css were previously reported to be active at very low
levels in normal globin genes (22) and our results system-
atically extend this ﬁnding. It is clear from Figure 3 that
some splice sites that have been classiﬁed as css are used
by normal genes at a relatively high frequency (lanes 2–5),
which is in accordance with the CSF analysis
(Supplementary Table S2). These css can therefore also
be regarded as alternative splice sites that are further
activated in disease.
Css and introns
We previously identiﬁed nine css within the coding region
of the actin gene family by experiment and reported an
eight out of nine exact match to the position of introns in
actin genes from other species (13,14). CSF identiﬁed eight
css within the coding region of the actin gene family of
which three were identical in position to the previously
identiﬁed actin css. Of the ﬁve new css identiﬁed by
CSF, three exactly match the position of introns in other
species, therefore extending our previous study and adding
further support to the validity of CSF predictions
(Supplementary Figure S2).
Because CSF predictions are sufﬁciently accurate, we
could use this program to establish whether there is a
general relationship between the position of css and
introns. We therefore analyzed an extensive intron
database compiled of some 80 genes from a wide range
of species that encode ribosomal proteins (23). Figure 4A
Figure 2. (A) CSF output for the human gene HBB for b-globin. (B) CSF output for WT1 (see text). The coordinates that are used refer to the
NCBI36/hg18 human genome assembly. It should be noted that HBB and WT1 genes align in a 30–50 direction with respect to their genome
coordinates.
5840 Nucleic Acids Research, 2011,Vol.39, No. 14shows a small part of this database that records the pos-
itions of introns against a 14 amino acid stretch of the
gene RPS5 from 23 species (ﬁle kindly provided by N.
Kenmochi). Introns that fall between codons are indicated
by red shading and introns that fall within codons are
indicated in blue (Phase 1) and green (Phase 2). For
example, there is an intron located within a codon for
valine (V) in the fungus Cryptococcus neoformans but in
no other listed species. This observation is typical in that
although introns are wide-spread among eukaryotes,
the vast majority of individual intron positions are
found in only a minority of species (Supplementary
Table S3) (18).
We screened for css in ribosomal protein genes from
human, mouse, Danio rerio and Arabidopsis thaliana and
identiﬁed 74, 41, 16 and 4 css, respectively, within coding
regions, these diminishing numbers simply reﬂect the
amount of EST data that is available. Alignment of the
predicted css indicates that the large majority are correct
because they conform to splice site consensus sequences
(Supplementary Table S4). All of these css were used at
low frequencies, similar to the HBB example of Figure 2A.
Figure 4B shows how we record the position of css; in this
example, there is a css in the human RPS5 gene that
exactly matches the position of introns in Drososphila
5 SLC35A1 229/97 bp
4  ALG3 232/194 bp
3  WT1 149/140 bp
2  OAS1 219/120 bp
161 bp 1   FANCA 3 2 14 5 6
6 SLC35A1 237 bp
Figure 3. Experimental conﬁrmation of CSF predictions. Predicted css are shown by the vertical boxes for the indicated genes. Active css would be
expected to generate PCR fragments of the sizes shown in the gene diagrams. PCR products marked with asterisks were sequenced in order to
conﬁrm the use of the predicted css (Supplementary Figure S3). Messenger RNA was prepared from the human cell lines K562 (lane 1); HEPG2
(lanes 2, 3) and primary mesenchymal stem cells (lanes 4–6) and used for RT–PCR with the indicated primers (see Supplementary Data).
   ^
 ** *
Hs NPLQVLVNAIINSG NPLQVLVNAIINSG   PYCIIKGKARLG
Mm NPLQVLVNAIINSG NPLQVLVNAIINSG   PYCIIKGKARLG 
Fr NPLQVLVNAIINSG NPLQVLVNAIINSG   PYCIVKGKARLG
Ci NPLQVLVNAIINSG NPLQVLVNAIINSG   PYCIVKGKSRLG
Ag NPLQIVVHAIINSG   NPLQIVVHAIINSG   PYCIIKGKARLG 
Dm NPLQILVSAIINSG   NPLQILVSAIINSG   PYCIVKGKARLG 
Am NPLQVLVTAIINSG   NPLQVLVTAIINSG   PYCIIKGKSRLG 
Ce NPVQVLVNAVINSG NPVQVLVNAVINSG   PYAIIKGKASLG 
Mg NPIQIAVDAIVNCG   NPIQIAVDAIVNCG   PYAIIKGKARLG 
Fg NPIQVAVDAIVNCG   NPIQVAVDAIVNCG   PYAIVKGKARLG 
Sn NPIQVAVDAIVNCG   NPIQVAVDAIVNCG   PYVIVKGKARLG 
Yl NPLQVVVDAIINCG   NPLQVVVDAIINCG   PYAIVKGKARLG 
Sc NPIQVVVDAITNTG   NPIQVVVDAITNTG   PYAIVKGKARLG 
Sp NPLQVLVDAVAACG   NPLQVLVDAVAACG   PYAIVKNKARLG 
Um NPIQIAVDAIVNCG   NPIQIAVDAIVNCG   PYVIVKSKASIG 
Ro NPLQILVDAIINCG   NPLQILVDAIINCG   PYCIVKGKARLG 
Cc NPIQVLVDAIVNTG   NPIQVLVDAIVNTG   PYVIVKGKARLG 
Cn NPIQVLVDAIINTG   NPIQVLVDAIINTG   PYVIVKGKARLG 
Dd NPLQVLVEAVMNSG   NPLQVLVEAVMNSG   PYCIVKSKSRLG 
Pf NPLQVFVNAVQKGG   NPLQVFVNAVQKGG   PYCIVKDKATLG 
At NPIQVIIDAIVNSG   NPIQVIIDAIVNSG   PYCIVKGKSRLG 
Os NPIQVIVDAIINSG   NPIQVIVDAIINSG   PYCIVKGKARLG 
Cr NPIQVVVDAIINSG   NPIQVVVDAIINSG   PYAIVKGKARLG
AB C
Figure 4. Comparison of intron and css positions for a small part of
the ribosomal protein gene database (23). (A) An alignment of 14
amino acids of the RPS5 gene that marks the position of introns for
23 species. (B) The same alignment including two css positions
identiﬁed by CSF. (C) An alignment of part of RPL7A that illustrates
the conservation of two css that also match an intron in
Chlamydomonas reinhardtii (Cr). * - marks the position of css that
match introns; ^ - marks conserved css.
Table 1. The alignment of css predictions by CSF reveals consensus
sequences typical of splice sites
Base (%)  5  4  3  2  112345
50 css predictions
T 28.8 17.6 21.2 14.1 11.8 0.6 90.6 5.9 11.8 10.0
C 22.4 24.1 27.6 17.1 4.7 0.6 7.6 11.8 20.0 12.9
G 24.1 34.7 25.3 17.6 63.5 97.1 0.6 40.6 30.0 63.5
A 24.1 19.4 25.3 50.6 19.4 1.2 0.6 41.2 37.6 12.9
30 css predictions
T 31.8 22.9 21.2 4.5 2.2 17.9 26.3 31.8 26.3 30.2
C 32.4 30.2 59.8 0.6 0.6 23.5 24.6 29.6 32.4 26.3
G 20.1 24.0 5.0 1.1 96.6 33.0 18.4 21.2 22.3 21.8
A 15.6 22.9 14.0 93.9 0.6 25.7 30.7 17.3 19.0 21.8
This Table is compiled from 169 and 179 examples of 50 and 30 css
predictions, respectively, that are supported by only single ESTs
(Supplementary Table S1). The relative proportions of the bases T,
C, G and A are shown as a percentage at ﬁve positions both
upstream and downstream of the predicted cryptic cleavage site. The
most frequently occurring bases are shaded.
Nucleic Acids Research, 2011,Vol.39, No. 14 5841(Dm) the honeybee (Am) and a fungus (Cc) and a nearby
css in the mouse (Mm) that exactly matches the position of
introns in three plant species (At, Os, Cr). We have
identiﬁed 135 css to date and of these at least ﬁve are
conserved between species (Figure 4C and
Supplementary Figure S4). Thirty-three out of 135 css of
the ribosomal gene family exactly match the position of
introns in other species (Supplementary Figure S4). This
proportion is smaller than the 11/14 match observed for
the actin gene family (Supplementary Figure S2), but is
still highly signiﬁcant (P=2.2 10
 15, see ‘Materials and
Methods’ section).
DISCUSSION
The CSF program is designed to identify transcripts that
are generated through the low level use of css by normal
genes. In addition, CSF also identiﬁes a subset of alterna-
tive splice sites that are similar to css, but are used at a
greater frequency. Both types of splice sites are reported to
be activated in genetic disease as a result of mutations that
disrupt the function of nearby competitive splice sites
(4,5). Our analyses show that css predictions by CSF are
very reliable and so we would expect, for example, that
many more of the predicted css and alternative splice sites
of Supplementary Table S1 will be discovered to be
associated with genetic disease. The identiﬁcation of css
by CSF is limited by the amount of available transcript
data but this will improve as further transcript sequences
become available, particularly with the advent of mRNA
deep sequencing (24).
CSF was designed primarily to identify css in highly
conserved gene families such as actin in order to
advance our understanding of intron origin. We found
that about 25% of the css within the coding sequence of
the large family of genes that encode ribosomal proteins
exactly match the position of introns that are present in
equivalent genes from other species (Figure 4 and
Supplementary Figure S4). This compares to a 78%
match between actin css and introns, however, there is
far more phylogenetic data available for the actin gene
family and so relatively more introns have been dis-
covered. Consequently, the css that are recorded in
Supplementary Figure S4 predict the positions of as yet
undiscovered introns in the ribosomal gene family.
The well-known and valuable early and late models of
intron origin both assume that the splicing machinery
evolved for the purpose of removing introns that were
either present in the most ancestral genomes or were
inserted after the separation of the prokaryotes (25–27).
At the time the models were proposed, non-intronic
splicing information was not generally thought to be of
major relevance and so is not an important feature of
either model (28).
However, it is now established that exon junction se-
quences are older and better conserved than most if not
all introns and were sites for intron insertions during evo-
lution (18,29–33). Indeed, a number of intron properties
such as their phasing with respect to the coding sequence
(29–30,34) and their location with respect to protein
structure have now been largely attributed to the
ﬂanking exon junction sequence (35,36).
Consequently, our ﬁnding that css often match the
position of exon junction sequences in gene homologues,
strongly indicates that css were targeted by intron inser-
tions during evolution. Our data also indicates that the
information that lies outside some introns is not only
conserved with homologs that lack such introns but is
also capable of being independently recognized by the
splicing machinery and can deﬁne the position of the
‘missing’ introns (13). This is a striking observation
because although the splicing information that ﬂanks
introns contributes to their recognition, there is no mech-
anistic reason for this information to be autonomous
rather than auxiliary in nature for the purpose of intron
removal (37). It is unlikely that a css is recognized from
the immediate splice-site information alone (8–10), sug-
gesting that other information such as splicing enhancer
sequences are also conserved between some gene homo-
logues independently of intron presence.
All of the available evidence indicates that the splicing
information that ﬂanks introns was largely in place prior
to their insertion (18,29–33). The key question we have
started to address here is whether such information
might have been functional. Our data so far does not
prove but it certainly supports the suggestion that infor-
mation of this nature could have been used by the splicing
machinery for splicing purposes prior to the arrival of
introns, which is a rather different concept to the early
and late models of intron origin (28).
The splicing information that ﬂanks introns is perhaps
similar to the splicing information that enables the mRNA
of intronless genes to interact with components of the
splicing machinery for the purpose of mRNA biogenesis,
nonsense mediated decay or alternative splicing (38–43).
For genes that have introns there are still many reports of
intron-independent splicing between exonic splice sites
(44–53). If intron-independent splicing is an ancestral
mechanism then it may be far more prevalent across
species than is currently realized.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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